FDA Adverse Event Other Summary report: N

ANGIOJET ULTRA XPEEDIOR

MDR report key: 1079457 · Received July 18, 2008

Report

Report Number
2183460-2008-00007
Event Type
Other
Date Received
July 18, 2008
Date of Event
June 3, 2008
Report Date
July 17, 2008
Manufacturer
POSSIS MEDICAL, INC.
Product Code
DXE
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVENT CONSISTS OF POST ANGIOJET THROMBECTOMY AND STENT PLACEMENT IN SFA BLEEDING FROM UNK SOURCE REQUIRING TWO UNITS RBC TRANSFUSION WITH NO SEQUELAE. PHYSICIAN THOUGHT EVENT WAS PROBABLY RELATED TO THE ANGIOJET THROMBECTOMY DEVICE AND PROCEDURE. BLEEDING IS A KNOWN RISK OF THROMBECTOMY AND STENTING PROCEDURE AND IS APPROPRIATELY DISCLOSED IN THE DEVICE LABELING. NO DEFICIENCY IN THE DEVICE OR LABELING IS ALLEGED OR SUSPECTED. THIS IS MDR REPORTABLE. NO FURTHER INVESTIGATION WARRANTED.

Description of Event or Problem · 1

(B) (4). PT IS AN (B) (6) FEMALE WHO UNDERWENT ANGIOPLASTY AND STENTING OF THE MID AND DISTAL LEFT SFA ON (B) (6) 2008. PT HAS A HISTORY OF HYPERTENSION, INTERMITTENT CLAUDICATION AND HYPERLIPIDEMIA. SHE PRESENTED ON (B) (6) 2008 WITH SUBACUTE LEFT LIMB ISCHEMIA SECONDARY TO THROMBOSIS OF THE PREVIOUSLY PLACED STENTS. ONSET OF S/S < 24 HOURS. THE LEFT SFA WAS COMPLETELY OCCLUDED. THE PT WAS TREATED WITH THROMBECTOMY AND STENT PLACEMENT IN THE SFA. FINAL ANGIOGRAPHIC ASSESSMENT SHOWED A PATENT SFA. ON (B) (6) 2008, THE PT PRESENTED WITH STENT THROMBOSIS SECONDARY TO NON-COMPLIANCE OF HER ANTIPLATELET MEDICATION. ON (B) (6) 2008, THE PT HAD BLEEDING FROM AN UNK SOURCE WHICH REQUIRED AN RBC TRANSFUSION OF TWO UNITS. THIS EVENT WAS THOUGHT TO BE PROBABLY RELATED TO THE ANGIOJET CATHETER AND THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANGIOJET ULTRA XPEEDIOR EMBOLECTOMY CATHETER DXE POSSIS MEDICAL, INC. 105040-001 UNK

Patients

Seq Age Sex Outcome Treatment
1 85 YR Life Threatening| R